Gene · 2829
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
561 to 580 of 1,173
Download this page as JSON| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| F30CA236466 | Exploring the Innate Sensors Underlying Cancer Immunosurveillance | 1 | 2021 |
| F31DE028740 | NLR and Oral Cancer Immune Escape | 1 | 2021 |
| F32CA233203 | Characterizing the immune and metabolic profiles of cutaneous T-cell lymphoma in formalin-fixed paraffin-embedded skin tissue samples | 1 | 2021 |
| F32CA250147 | CD40 agonism for the treatment of bladder cancer | 1 | 2021 |
| I01BX004033 | Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease | 1 | 2021 |
| K08CA241084 | Immune Evasion in Pancreatic Cancer | 1 | 2021 |
| K08DE026189 | Anti-Candida activity of CCL28 in oropharyngeal candidiasis | 1 | 2021 |
| K08DK114563 | Regulation of brown fat metabolism by the immune receptor PD-L1 | 1 | 2021 |
| K23HL138461 | Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic Sequencing | 1 | 2021 |
| K99GM135515 | Exploiting Natural Genetic and Organismic Variation to Identify the DNA Motifs Regulating Transcription | 1 | 2021 |
| P01AG017586 | Frontotemporal Dementias: Genotypes and Phenotypes | 1 | 2021 |
| P01AI131374 | Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption | 1 | 2021 |
| P01CA069246 | Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas | 1 | 2021 |
| P01HL108797 | Elafin Therapy for Pulmonary Arterial Hypertension | 1 | 2021 |
| P01HL108808 | Development of Novel Mycolytic Therapies for Lung Disease | 1 | 2021 |
| R00HL138163 | ATHEROSCLEROTIC LESION INITIATION BY RESIDENT AORTIC MACROPHAGE PROLIFERATION | 1 | 2021 |
| R01AG053498 | Metabolic alterations in age-associated dendritic cell dysfunction | 1 | 2021 |
| R01AI028433 | Immune System Modeling/HIV | 1 | 2021 |
| R01AI079187 | UNIQUE ROLES OF ANTIGEN PRESENTING CELLS ON T CELL TOLERANCE AND AUTOIMMUNITY | 1 | 2021 |
| R01AI089805 | Novel Requirements for Akt1 in T Cell Commitment | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/grants?page=29